KEGG   PATHWAY: pyu05213
Entry
pyu05213                    Pathway                                
Name
Endometrial cancer - Puma yagouaroundi (jaguarundi)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
pyu05213  Endometrial cancer
pyu05213

Disease
H00026  Endometrial cancer
Organism
Puma yagouaroundi (jaguarundi) [GN:pyu]
Gene
121009705  CDH1; cadherin-1 [KO:K05689]
121010702  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
121010770  CTNNA1; catenin alpha-1 [KO:K05691]
121011002  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
121011444  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
121011897  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
121013741  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
121014378  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
121014969  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
121015111  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
121015318  AXIN2; axin-2 [KO:K04385]
121015982  TP53; cellular tumor antigen p53 [KO:K04451]
121016570  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
121017018  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
121017912  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
121018751  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
121019121  TCF7L1; transcription factor 7-like 1 [KO:K04490]
121019187  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
121019662  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
121019790  AXIN1; axin-1 isoform X1 [KO:K02157]
121020585  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
121021126  ILK; integrin-linked protein kinase isoform X1 [KO:K06272] [EC:2.7.11.1]
121021383  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
121021432  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
121021465  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
121021539  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
121022226  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
121022826  HRAS; GTPase HRas isoform X1 [KO:K02833]
121023018  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
121023852  CCND1; G1/S-specific cyclin-D1 isoform X1 [KO:K04503]
121023947  BAD; bcl2-associated agonist of cell death [KO:K02158]
121026094  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
121026171  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
121027050  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
121027286  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
121027738  NRAS; GTPase NRas [KO:K07828]
121028241  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
121029294  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
121029363  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
121029870  FOXO3; forkhead box protein O3 [KO:K09408]
121031012  EGF; LOW QUALITY PROTEIN: pro-epidermal growth factor [KO:K04357]
121031433  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
121031737  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
121032358  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
121033449  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
121033506  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
121033733  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
121034018  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
121036286  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
121036689  CTNNA3; catenin alpha-3 [KO:K05691]
121037238  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
121038809  KRAS; GTPase KRas isoform X1 [KO:K07827]
121041241  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
121041863  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
121042977  MYC; myc proto-oncogene protein [KO:K04377]
121043455  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
121044367  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
121044914  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
pyu04010  MAPK signaling pathway
pyu04012  ErbB signaling pathway
pyu04060  Cytokine-cytokine receptor interaction
pyu04110  Cell cycle
pyu04115  p53 signaling pathway
pyu04151  PI3K-Akt signaling pathway
pyu04310  Wnt signaling pathway
pyu04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system